Vimarsana
Biggest News Aggregation in the World

Page 19 - Appendix Figure News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Appendix Figure. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Appendix Figure Today - Breaking & Trending Today

Early Release - Geographic Range of Recreational Water-Associated Primary Amebic Meningoencephalitis, United States, 1978–2018 - Volume 27, Number 1—January 2021 - Emerging Infectious Diseases journal - Vimarsana News

Early Release - Geographic Range of Recreational Water-Associated Primary Amebic Meningoencephalitis, United States, 1978–2018 - Volume 27, Number 1—January 2021 - Emerging Infectious Diseases journal

N. fowleri suggests it might be sensitive to global changes in surface temperature ( – 12). Analysis of recreational water exposures resulting in PAM could aid risk prediction, prevention, and public communication efforts. The US Centers for Disease Control and Prevention (CDC) maintains a database of reported PAM cases in the United States since 1962, cataloging information about dates, locations, and suspected exposures ( 2). In 1978, CDC established its Free-living Ameba Laboratory, which increased the national capacity for clinical testing and contributed to an increase in the number of...

Source: cdc.gov
Early Release - Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan - Volume 27, Number 1—January 2021 - Emerging Infectious Diseases journal - Vimarsana News

Early Release - Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan - Volume 27, Number 1—January 2021 - Emerging Infectious Diseases journal

Abstract Rwanda and Bhutan, 2 low- and middle-income countries, implemented primarily school-based national human papillomavirus (HPV) vaccination in 2011 (Rwanda) and 2010 (Bhutan). We estimated vaccination effectiveness through urine-based HPV prevalence surveys in schools in 2013–2014 and 2017. In Rwanda, 912 participants from baseline surveys and 1,087 from repeat surveys were included, and in Bhutan, 973 participants from baseline surveys and 909 from repeat surveys were included. The overall effectiveness against vaccine-targeted HPV types (i.e., HPV-6/11/16/18) was 78% (95% CI 51%–...

Source: cdc.gov